Wellington Management Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4,182,312
| Closed | -$81.3M | – | 2395 |
|
|
2018
Q1 | $81.3M | Buy |
4,182,312
+45,687
| +1% | +$897K | 0.02% | 642 |
|
|
2017
Q4 | $68.9M | Buy |
+4,136,625
| New | +$75.8M | 0.02% | 675 |
|
|
2017
Q1 | – | Sell |
-121,200
| Closed | -$1.61M | – | 2358 |
|
|
2016
Q4 | $1.61M | Buy |
121,200
+67,798
| +127% | +$1.16M | ﹤0.01% | 1750 |
|
|
2016
Q3 | $1.27M | Buy |
+53,402
| New | +$1.44M | ﹤0.01% | 1783 |
|
|
2015
Q3 | – | Sell |
-17,161
| Closed | -$788K | – | 2289 |
|
|
2015
Q2 | $788K | Sell |
17,161
-50,005
| -74% | -$2.37M | ﹤0.01% | 1882 |
|
|
2015
Q1 | $3.15M | Sell |
67,166
-14,937
| -18% | -$594K | ﹤0.01% | 1575 |
|
|
2014
Q4 | $2.6M | Buy |
82,103
+27,348
| +50% | +$800K | ﹤0.01% | 1623 |
|
|
2014
Q3 | $1.3M | Sell |
54,755
-240,643
| -81% | -$6.16M | ﹤0.01% | 1771 |
|
|
2014
Q2 | $8.86M | Buy |
295,398
+47,619
| +19% | +$1.28M | ﹤0.01% | 1283 |
|
|
2014
Q1 | $6.55M | Buy |
247,779
+187,799
| +313% | +$4.69M | ﹤0.01% | 1369 |
|
|
2013
Q4 | $1.51M | Buy |
59,980
+43,980
| +275% | +$981K | ﹤0.01% | 1760 |
|
|
2013
Q3 | $328K | Hold |
16,000
| – | – | ﹤0.01% | 2055 |
|
|
2013
Q2 | $319K | Buy |
+16,000
| New | +$284K | ﹤0.01% | 2022 |
|
Wellington Management Group's IPXL Position: Q2 2018 in Review
Wellington Management Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 4,182,312 shares — an estimated $81.3M sold.
Wellington Management Group first reported a position in IPXL in Q2 2013 and held it in 13 quarters. The position peaked at $81.3M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Wellington Management Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Wellington Management Group sold 4,182,312 Impax Laboratories, Inc. shares in Q2 2018, an estimated $81.3M.
- Wellington Management Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 13 quarters.
- Wellington Management Group's Impax Laboratories, Inc. position peaked at $81.3M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Wellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.